Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wallis

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2024
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 CountriesN Sarita Shah, Cissy Kityo, Michael D Hughes, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
The British Journal of Surgery|March 13, 2026
The Governance of Surgical Innovation in the UK National Health ServiceJ M Blazeby, H S Richards, S Cousins, et al.
Open Forum Infectious Diseases|July 9, 2025
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 SitesCissy Kityo, Caitlyn McCarthy, Serena P Koenig, et al.
AIDS Research and Human Retroviruses|November 25, 2010
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern AfricaMatt A Price, Carole L Wallis, Shabir Lakhi, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2015
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical TrialRami Kantor, Laura Smeaton, Saran Vardhanabhuti, et al.
Journal of the International AIDS Society|August 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South AfricaUrvi M Parikh, Lauren D Kudrick, Lisa Levy, et al.
Plos Pathogens|December 7, 2019
Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East AfricaNuno R Faria, Nicole Vidal, José Lourenco, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2024
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 CountriesN Sarita Shah, Cissy Kityo, Michael D Hughes, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
The British Journal of Surgery|March 13, 2026
The Governance of Surgical Innovation in the UK National Health ServiceJ M Blazeby, H S Richards, S Cousins, et al.
Open Forum Infectious Diseases|July 9, 2025
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 SitesCissy Kityo, Caitlyn McCarthy, Serena P Koenig, et al.
AIDS Research and Human Retroviruses|November 25, 2010
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern AfricaMatt A Price, Carole L Wallis, Shabir Lakhi, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2015
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical TrialRami Kantor, Laura Smeaton, Saran Vardhanabhuti, et al.
Journal of the International AIDS Society|August 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South AfricaUrvi M Parikh, Lauren D Kudrick, Lisa Levy, et al.
Plos Pathogens|December 7, 2019
Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East AfricaNuno R Faria, Nicole Vidal, José Lourenco, et al.
Pageof 19